SB 1091

  • Pennsylvania Senate Bill
  • 2019-2020 Regular Session
  • Introduced in Senate
  • Senate
  • House
  • Governor

An Act providing for pharmaceutical transparency; establishing the Pharmaceutical Transparency Review Board and providing for its powers and duties; and establishing the Pharmaceutical Transparency Review Fund.

Abstract

Bill Sponsors (16)

Daniel Laughlin

  • Republican
  • upper
  • 49
Primary

Sharif Street

  • Democratic
  • upper
  • 3
Cosponsor

Christine M. Tartaglione

  • Democratic
  • upper
  • 2
Cosponsor

Daylin Leach

  • Democratic
  • upper
  • 17
Cosponsor

Patrick J. Stefano

  • Republican
  • upper
  • 32
Cosponsor

Lisa M. Boscola

  • Democratic
  • upper
  • 18
Cosponsor

Collett

Cosponsor

John P. Sabatina

  • Democratic
  • upper
  • 5
Cosponsor

Lawrence M. Farnese

  • Democratic
  • upper
  • 1
Cosponsor

Costa

Cosponsor

James R. Brewster

  • Democratic
  • upper
  • 45
Cosponsor

Art Haywood

  • Democratic
  • upper
  • 4
Cosponsor

John T. Yudichak

  • Democratic
  • upper
  • 14
Cosponsor

John P. Blake

  • Democratic
  • upper
  • 22
Cosponsor

Joe Pittman

  • Republican
  • upper
  • 41
Cosponsor

Camera Bartolotta

  • Republican
  • upper
  • 46
Cosponsor

Votes


No votes to display

Actions


Mar 25, 2020

Senate

PN 1605 Referred to BANKING AND INSURANCE

Bill Text

Bill Text Versions Format
Printer's No. 1605 MSWORD PDF HTML

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated nightly from the official website of the Pennsylvania General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.